Europe Dermatological Therapeutics Market 2019-2028

2.1. Market Definition
2.2. Key Insights
2.2.1. Advancements in Biologics
2.2.2. Atopic Dermatitis is Anticipated to Grow at Highest CAGR
2.3. Porter's Five Forces Analysis
2.3.1. Threat of New Entrants
2.3.2. Threat of Substitute
2.3.3. Bargaining Power of Suppliers
2.3.4. Bargaining Power of Buyers
2.3.5. Threat of Competitive Rivalry
2.4. Impact of COVID-19 – Dermatological Therapeutics
2.5. Market Attractiveness Index
2.6. Vendor Scorecard
2.7. Market Drivers
2.7.1. Increasing Burden of Dermatological Diseases
2.8. Market Restraints
2.8.1. Grave Side-Effects of Certain Classes of Therapeutic Drugs
2.9. Market Opportunities
2.9.1. Rise in Awareness Levels of Disease Origin and Progression
2.10. Market Challenges
2.10.1. Unawareness Regarding Dermatological Diagnosis

3.1. Anti-Infectives
3.2. Corticosteroids
3.3. Anti-Acne
3.4. Calcineurin Inhibitors
3.5. Retinoids
3.6. Other Drug Classes

4.1. Alopecia
4.2. Herpes
4.3. Psoriasis
4.4. Rosacea
4.5. Atopic Dermatitis
4.6. Acne Vulgaris
4.7. Other Applications

5.1. Europe
5.1.1. United Kingdom
5.1.2. Germany
5.1.3. France
5.1.4. Spain
5.1.5. Italy
5.1.6. Russia
5.1.7. Rest of Europe

6.1. Abbvie Inc
6.2. Allergan
6.3. Almirall
6.4. Amgen Inc
6.5. Bausch Health Companies Inc
6.6. Galderma
6.7. GlaxoSmithKline plc
6.8. Johnson & Johnson
6.9. Novartis Ag
6.10. Pfizer Inc
6.11. AGI Dermatics
6.12. Leo Pharma A/S
6.13. Merck & Co

7.1. Research Scope & Deliverables
7.2. Sources of Data
7.3. Research Methodology

Table 1: Europe Dermatological Therapeutics Market, by Country, 2019-2028 (In $ Billion)
Table 2: Market Attractiveness Index
Table 3: Vendor Scorecard
Table 4: Europe Dermatological Therapeutics Market, by Country, 2019-2028 (In $ Billion)
Table 5: Europe Dermatological Therapeutics Market, by Drug Class, 2019-2028 (In $ Billion)
Table 6: Europe Dermatological Therapeutics Market, by Application, 2019-2028 (In $ Billion)

Figure 1: Porter's Five Forces Analysis
Figure 2: Europe Dermatological Therapeutics Market, by Anti-Infectives, 2019-2028 (In $ Billion)
Figure 3: Europe Dermatological Therapeutics Market, by Corticosteroids, 2019-2028 (In $ Billion)
Figure 4: Europe Dermatological Therapeutics Market, by Anti-Acne, 2019-2028 (In $ Billion)
Figure 5: Europe Dermatological Therapeutics Market, by Calcineurin Inhibitors, 2019-2028 (In $ Billion)
Figure 6: Europe Dermatological Therapeutics Market, by Retinoids, 2019-2028 (In $ Billion)
Figure 7: Europe Dermatological Therapeutics Market, by Other Drug Classes, 2019-2028 (In $ Billion)
Figure 8: Europe Dermatological Therapeutics Market, by Alopecia, 2019-2028 (In $ Billion)
Figure 9: Europe Dermatological Therapeutics Market, by Herpes, 2019-2028 (In $ Billion)
Figure 10: Europe Dermatological Therapeutics Market, by Psoriasis, 2019-2028 (In $ Billion)
Figure 11: Europe Dermatological Therapeutics Market, by Rosacea, 2019-2028 (In $ Billion)
Figure 12: Europe Dermatological Therapeutics Market, by Atopic Dermatitis, 2019-2028 (In $ Billion)
Figure 13: Europe Dermatological Therapeutics Market, by Acne Vulgaris, 2019-2028 (In $ Billion)
Figure 14: Europe Dermatological Therapeutics Market, by Other Applications, 2019-2028 (In $ Billion)
Figure 15: Europe Dermatological Therapeutics Market, Regional Outlook, 2019 & 2028 (In %)
Figure 16: United Kingdom Dermatological Therapeutics Market 2019-2028 (In $ Billion)
Figure 17: Germany Dermatological Therapeutics Market 2019-2028 (In $ Billion)
Figure 18: France Dermatological Therapeutics Market 2019-2028 (In $ Billion)
Figure 19: Spain Dermatological Therapeutics Market 2019-2028 (In $ Billion)
Figure 20: Italy Dermatological Therapeutics Market 2019-2028 (In $ Billion)
Figure 21: Russia Dermatological Therapeutics Market 2019-2028 (In $ Billion)
Figure 22: Rest of Europe Dermatological Therapeutics Market 2019-2028 (In $ Billion)